Global Drugs for Chronic Obstructive Pulmonary Disorder Sales Market Report 2017

February 2017 | 127 pages | ID: G7DCA2ED743EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Drugs for Chronic Obstructive Pulmonary Disorder

Revenue, means the sales value of Drugs for Chronic Obstructive Pulmonary Disorder

This report studies sales (consumption) of Drugs for Chronic Obstructive Pulmonary Disorder in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• AstraZeneca
• Boehringer Ingelheim
• GSK
• Novartis
• Teva Pharmaceuticals
• Ache Laboratorios Farmaceuticos
• Almirall
• Aquinox Pharmaceuticals
• Ario Pharma
• Asmacure
• Astellas Pharma
• BioMarck Pharmaceuticals
• Others

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Drugs for Chronic Obstructive Pulmonary Disorder in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan
• Southeast Asia
• India

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Short-Acting Bronchodilators
• Corticosteroids
• Methylxanthines
• Long-Acting Bronchodilators
• Phosphodiesterase-4 Inhibitors

Split by applications, this report focuses on sales, market share and growth rate of Drugs for Chronic Obstructive Pulmonary Disorder in each application, can be divided into

• GOLD 1： FEV1 ≥ 80%
• GOLD 2： 50% ≤ FEV1 < 80%
• GOLD 3： 30% ≤ FEV1 < 50%
• GOLD 4： FEV1 < 30%

Contents

Global Drugs for Chronic Obstructive Pulmonary Disorder Sales Market Report 2017

1 DRUGS FOR CHRONIC OBSTRUCTIVE PULMONARY DISORDER OVERVIEW

1.1 Product Overview and Scope of Drugs for Chronic Obstructive Pulmonary Disorder
1.2 Classification of Drugs for Chronic Obstructive Pulmonary Disorder
  1.2.1 Short-Acting Bronchodilators
  1.2.2 Corticosteroids
  1.2.3 Methylxanthines
  1.2.4 Long-Acting Bronchodilators
  1.2.5 Phosphodiesterase-4 Inhibitors
1.3 Application of Drugs for Chronic Obstructive Pulmonary Disorder
  1.3.1 GOLD 1： FEV1 ≥ 80%
  1.3.2 GOLD 2： 50% ≤ FEV1 < 80%
  1.3.3 GOLD 3： 30% ≤ FEV1 < 50%
  1.3.4 GOLD 4： FEV1 < 30%
1.4 Drugs for Chronic Obstructive Pulmonary Disorder Market by Regions
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 Japan Status and Prospect (2012-2022)
  1.4.5 Southeast Asia Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Drugs for Chronic Obstructive Pulmonary Disorder (2012-2022)
  1.5.1 Global Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2022)
  1.5.2 Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2022)

2 GLOBAL DRUGS FOR CHRONIC OBSTRUCTIVE PULMONARY DISORDER COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Drugs for Chronic Obstructive Pulmonary Disorder Market Competition by Manufacturers
  2.1.1 Global Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share of Key Manufacturers (2012-2017)
  2.1.2 Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Share by Manufacturers (2012-2017)
2.2 Global Drugs for Chronic Obstructive Pulmonary Disorder (Volume and Value) by Type
  2.2.1 Global Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type (2012-2017)
  2.2.2 Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Market Share by Type (2012-2017)
2.3 Global Drugs for Chronic Obstructive Pulmonary Disorder (Volume and Value) by Regions
  2.3.1 Global Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Regions (2012-2017)
  2.3.2 Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Market Share by Regions (2012-2017)
2.4 Global Drugs for Chronic Obstructive Pulmonary Disorder (Volume) by Application

3 UNITED STATES DRUGS FOR CHRONIC OBSTRUCTIVE PULMONARY DISORDER (VOLUME, VALUE AND SALES PRICE)

3.1 United States Drugs for Chronic Obstructive Pulmonary Disorder Sales and Value (2012-2017)
  3.1.1 United States Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
  3.1.2 United States Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
  3.1.3 United States Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
3.2 United States Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Manufacturers
3.3 United States Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type
3.4 United States Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Application

4 CHINA DRUGS FOR CHRONIC OBSTRUCTIVE PULMONARY DISORDER (VOLUME, VALUE AND SALES PRICE)

4.1 China Drugs for Chronic Obstructive Pulmonary Disorder Sales and Value (2012-2017)
  4.1.1 China Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
  4.1.2 China Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
  4.1.3 China Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
4.2 China Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Manufacturers
4.3 China Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type
4.4 China Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Application

5 EUROPE DRUGS FOR CHRONIC OBSTRUCTIVE PULMONARY DISORDER (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales and Value (2012-2017)
  5.1.1 Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
  5.1.2 Europe Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
5.2 Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Manufacturers
5.3 Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type
5.4 Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Application

6 JAPAN DRUGS FOR CHRONIC OBSTRUCTIVE PULMONARY DISORDER (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Drugs for Chronic Obstructive Pulmonary Disorder Sales and Value (2012-2017)
  6.1.1 Japan Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
  6.1.2 Japan Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
6.2 Japan Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Manufacturers
6.3 Japan Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type
6.4 Japan Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Application

7 SOUTHEAST ASIA DRUGS FOR CHRONIC OBSTRUCTIVE PULMONARY DISORDER (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Sales and Value (2012-2017)
  7.1.1 Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
7.2 Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Manufacturers
7.3 Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type
7.4 Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Application

8 INDIA DRUGS FOR CHRONIC OBSTRUCTIVE PULMONARY DISORDER (VOLUME, VALUE AND SALES PRICE)

8.1 India Drugs for Chronic Obstructive Pulmonary Disorder Sales and Value (2012-2017)
  8.1.1 India Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
  8.1.2 India Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
  8.1.3 India Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
8.2 India Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Manufacturers
8.3 India Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type
8.4 India Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Application

9 GLOBAL DRUGS FOR CHRONIC OBSTRUCTIVE PULMONARY DISORDER MANUFACTURERS ANALYSIS

9.1 AstraZeneca
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
    9.1.2.1 Short-Acting Bronchodilators
    9.1.2.2 Corticosteroids
  9.1.3 AstraZeneca Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Boehringer Ingelheim
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
    9.2.2.1 Short-Acting Bronchodilators
    9.2.2.2 Corticosteroids
  9.2.3 Boehringer Ingelheim Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 GSK
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
    9.3.2.1 Short-Acting Bronchodilators
    9.3.2.2 Corticosteroids
  9.3.3 GSK Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Novartis
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
    9.4.2.1 Short-Acting Bronchodilators
    9.4.2.2 Corticosteroids
  9.4.3 Novartis Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Teva Pharmaceuticals
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
    9.5.2.1 Short-Acting Bronchodilators
    9.5.2.2 Corticosteroids
  9.5.3 Teva Pharmaceuticals Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 Ache Laboratorios Farmaceuticos
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
    9.6.2.1 Short-Acting Bronchodilators
    9.6.2.2 Corticosteroids
  9.6.3 Ache Laboratorios Farmaceuticos Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 Almirall
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
    9.7.2.1 Short-Acting Bronchodilators
    9.7.2.2 Corticosteroids
  9.7.3 Almirall Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Aquinox Pharmaceuticals
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
    9.8.2.1 Short-Acting Bronchodilators
    9.8.2.2 Corticosteroids
  9.8.3 Aquinox Pharmaceuticals Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 Ario Pharma
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
    9.9.2.1 Short-Acting Bronchodilators
    9.9.2.2 Corticosteroids
  9.9.3 Ario Pharma Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 Asmacure
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
    9.10.2.1 Short-Acting Bronchodilators
    9.10.2.2 Corticosteroids
  9.10.3 Asmacure Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview
9.11 Astellas Pharma
9.12 BioMarck Pharmaceuticals
9.13 Others

10 DRUGS FOR CHRONIC OBSTRUCTIVE PULMONARY DISORDER MAUFACTURING COST ANALYSIS

10.1 Drugs for Chronic Obstructive Pulmonary Disorder Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Drugs for Chronic Obstructive Pulmonary Disorder
10.3 Manufacturing Process Analysis of Drugs for Chronic Obstructive Pulmonary Disorder

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Drugs for Chronic Obstructive Pulmonary Disorder Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Drugs for Chronic Obstructive Pulmonary Disorder Major Manufacturers in 2015
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL DRUGS FOR CHRONIC OBSTRUCTIVE PULMONARY DISORDER MARKET FORECAST (2017-2022)

14.1 Global Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate Forecast (2017-2022)
  14.1.2 Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Drugs for Chronic Obstructive Pulmonary Disorder Price and Trend Forecast (2017-2022)
14.2 Global Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.1 United States Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.2 China Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.3 Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 Japan Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 India Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Drugs for Chronic Obstructive Pulmonary Disorder Sales Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Drugs for Chronic Obstructive Pulmonary Disorder
Table Classification of Drugs for Chronic Obstructive Pulmonary Disorder
Figure Global Sales Market Share of Drugs for Chronic Obstructive Pulmonary Disorder by Type in 2015
Figure Short-Acting Bronchodilators Picture
Figure Corticosteroids Picture
Figure Methylxanthines Picture
Figure Long-Acting Bronchodilators Picture
Figure Phosphodiesterase-4 Inhibitors Picture
Table Applications of Drugs for Chronic Obstructive Pulmonary Disorder
Figure Global Sales Market Share of Drugs for Chronic Obstructive Pulmonary Disorder by Application in 2015
Figure GOLD 1： FEV1 ≥ 80% Examples
Figure GOLD 2： 50% ≤ FEV1 < 80% Examples
Figure GOLD 3： 30% ≤ FEV1 < 50% Examples
Figure GOLD 4： FEV1 < 30% Examples
Figure United States Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2022)
Figure China Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2022)
Figure Europe Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2022)
Figure Japan Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2022)
Figure India Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2022)
Figure Global Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2022)
Figure Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2022)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Sales of Key Manufacturers (2012-2017)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Sales Share by Manufacturers (2012-2017)
Figure 2015 Drugs for Chronic Obstructive Pulmonary Disorder Sales Share by Manufacturers
Figure 2016 Drugs for Chronic Obstructive Pulmonary Disorder Sales Share by Manufacturers
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue by Manufacturers (2012-2017)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue Share by Manufacturers
Table 2016 Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue Share by Manufacturers
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type (2012-2017)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Sales Share by Type (2012-2017)
Figure Sales Market Share of Drugs for Chronic Obstructive Pulmonary Disorder by Type (2012-2017)
Figure Global Drugs for Chronic Obstructive Pulmonary Disorder Sales Growth Rate by Type (2012-2017)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Market Share by Type (2012-2017)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Drugs for Chronic Obstructive Pulmonary Disorder by Type (2012-2017)
Figure Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue Growth Rate by Type (2012-2017)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Regions (2012-2017)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Sales Share by Regions (2012-2017)
Figure Sales Market Share of Drugs for Chronic Obstructive Pulmonary Disorder by Regions (2012-2017)
Figure Global Drugs for Chronic Obstructive Pulmonary Disorder Sales Growth Rate by Regions (2012-2017)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Market Share by Regions (2012-2017)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Drugs for Chronic Obstructive Pulmonary Disorder by Regions (2012-2017)
Figure Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue Growth Rate by Regions (2012-2017)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Application (2012-2017)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Sales Share by Application (2012-2017)
Figure Sales Market Share of Drugs for Chronic Obstructive Pulmonary Disorder by Application (2012-2017)
Figure Global Drugs for Chronic Obstructive Pulmonary Disorder Sales Growth Rate by Application (2012-2017)
Figure United States Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
Figure United States Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
Figure United States Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
Table United States Drugs for Chronic Obstructive Pulmonary Disorder Sales by Manufacturers (2012-2017)
Table United States Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Manufacturers (2012-2017)
Table United States Drugs for Chronic Obstructive Pulmonary Disorder Sales by Type (2012-2017)
Table United States Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Type (2012-2017)
Table United States Drugs for Chronic Obstructive Pulmonary Disorder Sales by Application (2012-2017)
Table United States Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Application (2012-2017)
Figure China Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
Figure China Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
Figure China Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
Table China Drugs for Chronic Obstructive Pulmonary Disorder Sales by Manufacturers (2012-2017)
Table China Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Manufacturers (2012-2017)
Table China Drugs for Chronic Obstructive Pulmonary Disorder Sales by Type (2012-2017)
Table China Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Type (2012-2017)
Table China Drugs for Chronic Obstructive Pulmonary Disorder Sales by Application (2012-2017)
Table China Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Application (2012-2017)
Figure Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
Figure Europe Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
Figure Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
Table Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales by Manufacturers (2012-2017)
Table Europe Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Manufacturers (2012-2017)
Table Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales by Type (2012-2017)
Table Europe Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Type (2012-2017)
Table Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales by Application (2012-2017)
Table Europe Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Application (2012-2017)
Figure Japan Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
Figure Japan Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
Figure Japan Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
Table Japan Drugs for Chronic Obstructive Pulmonary Disorder Sales by Manufacturers (2012-2017)
Table Japan Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Manufacturers (2012-2017)
Table Japan Drugs for Chronic Obstructive Pulmonary Disorder Sales by Type (2012-2017)
Table Japan Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Type (2012-2017)
Table Japan Drugs for Chronic Obstructive Pulmonary Disorder Sales by Application (2012-2017)
Table Japan Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Application (2012-2017)
Figure Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
Figure Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
Table Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Sales by Manufacturers (2012-2017)
Table Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Manufacturers (2012-2017)
Table Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Sales by Type (2012-2017)
Table Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Type (2012-2017)
Table Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Sales by Application (2012-2017)
Table Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Application (2012-2017)
Figure India Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
Figure India Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
Figure India Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
Table India Drugs for Chronic Obstructive Pulmonary Disorder Sales by Manufacturers (2012-2017)
Table India Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Manufacturers (2012-2017)
Table India Drugs for Chronic Obstructive Pulmonary Disorder Sales by Type (2012-2017)
Table India Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Type (2012-2017)
Table India Drugs for Chronic Obstructive Pulmonary Disorder Sales by Application (2012-2017)
Table India Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Application (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca Drugs for Chronic Obstructive Pulmonary Disorder Global Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Drugs for Chronic Obstructive Pulmonary Disorder Global Market Share (2012-2017)
Table GSK Basic Information List
Table GSK Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GSK Drugs for Chronic Obstructive Pulmonary Disorder Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Drugs for Chronic Obstructive Pulmonary Disorder Global Market Share (2012-2017)
Table Teva Pharmaceuticals Basic Information List
Table Teva Pharmaceuticals Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Teva Pharmaceuticals Drugs for Chronic Obstructive Pulmonary Disorder Global Market Share (2012-2017)
Table Ache Laboratorios Farmaceuticos Basic Information List
Table Ache Laboratorios Farmaceuticos Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Ache Laboratorios Farmaceuticos Drugs for Chronic Obstructive Pulmonary Disorder Global Market Share (2012-2017)
Table Almirall Basic Information List
Table Almirall Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Almirall Drugs for Chronic Obstructive Pulmonary Disorder Global Market Share (2012-2017)
Table Aquinox Pharmaceuticals Basic Information List
Table Aquinox Pharmaceuticals Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Aquinox Pharmaceuticals Drugs for Chronic Obstructive Pulmonary Disorder Global Market Share (2012-2017)
Table Ario Pharma Basic Information List
Table Ario Pharma Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Ario Pharma Drugs for Chronic Obstructive Pulmonary Disorder Global Market Share (2012-2017)
Table Asmacure Basic Information List
Table Asmacure Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Asmacure Drugs for Chronic Obstructive Pulmonary Disorder Global Market Share (2012-2017)
Table Astellas Pharma Basic Information List
Table BioMarck Pharmaceuticals Basic Information List
Table Others Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Chronic Obstructive Pulmonary Disorder
Figure Manufacturing Process Analysis of Drugs for Chronic Obstructive Pulmonary Disorder
Figure Drugs for Chronic Obstructive Pulmonary Disorder Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Chronic Obstructive Pulmonary Disorder Major Manufacturers in 2015
Table Major Buyers of Drugs for Chronic Obstructive Pulmonary Disorder
Table Distributors/Traders List
Figure Global Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate Forecast (2017-2022)
Figure Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate Forecast (2017-2022)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Sales Forecast by Regions (2017-2022)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Sales Forecast by Type (2017-2022)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Sales Forecast by Application (2017-2022)